Core Insights - Therma Bright Inc. has secured a strategic commercial order for an initial 100 Venowave™ units from Horizon Health, marking a significant step in its commercial scaling strategy [1][4] - The partnership with Horizon Health positions Venowave™ to capture a substantial share of the vascular recovery market in the U.S., leveraging Horizon's established network [3][4] Company Developments - The order follows a successful proof-of-concept phase in 2025, during which Therma Bright optimized its delivery and support protocols for the U.S. market [2] - Horizon Health, a leader in durable medical equipment, has a network that prescribes over 3,000 compression products monthly, enhancing the potential reach of Venowave™ [3][6] Market Expansion - Therma Bright is exploring opportunities to position Venowave™ for cosmetic applications in wellness and aesthetic healthcare clinics, indicating potential growth in the cosmetic wellness market [5] - Preliminary feedback suggests that Venowave™ could support lymphatic drainage and post-procedure recovery, expanding its application beyond clinical settings [5]
Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually
TMX Newsfile·2026-03-31 10:30